Eligibility Colorectal Cancer NCT01266564

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, age >/=18 years
Beschreibung

Adult | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
proven metastatic colorectal carcinoma
Beschreibung

Secondary malignant neoplasm of large intestine

Datentyp

boolean

Alias
UMLS CUI [1]
C0346973
patients have measurable disease
Beschreibung

Measurable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
patients are eligible to receive first-line avastin
Beschreibung

First line treatment | Avastin

Datentyp

boolean

Alias
UMLS CUI [1]
C1708063
UMLS CUI [2]
C1135130
patients have signed data release form
Beschreibung

Patient data Release Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2707520
UMLS CUI [1,2]
C1283071
UMLS CUI [1,3]
C1511481
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
contra-indication to receive avastin according to the local labeling
Beschreibung

Medical contraindication Avastin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1135130
participation in a clinical study within 30 days prior to enrolment
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
patients have any other primary cancer
Beschreibung

Primary malignant neoplasm Other

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1306459
UMLS CUI [1,2]
C0205394
concomitant treatment with other biologics
Beschreibung

Biological agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0005515
history of other malignant disease in the past 5 years except basal cell carcinoma
Beschreibung

Cancer Other | Exception Basal cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117

Ähnliche Modelle

Eligibility Colorectal Cancer NCT01266564

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, age >/=18 years
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Secondary malignant neoplasm of large intestine
Item
proven metastatic colorectal carcinoma
boolean
C0346973 (UMLS CUI [1])
Measurable Disease
Item
patients have measurable disease
boolean
C1513041 (UMLS CUI [1])
First line treatment | Avastin
Item
patients are eligible to receive first-line avastin
boolean
C1708063 (UMLS CUI [1])
C1135130 (UMLS CUI [2])
Patient data Release Consent
Item
patients have signed data release form
boolean
C2707520 (UMLS CUI [1,1])
C1283071 (UMLS CUI [1,2])
C1511481 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Avastin
Item
contra-indication to receive avastin according to the local labeling
boolean
C1301624 (UMLS CUI [1,1])
C1135130 (UMLS CUI [1,2])
Study Subject Participation Status
Item
participation in a clinical study within 30 days prior to enrolment
boolean
C2348568 (UMLS CUI [1])
Primary malignant neoplasm Other
Item
patients have any other primary cancer
boolean
C1306459 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Biological agents
Item
concomitant treatment with other biologics
boolean
C0005515 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma
Item
history of other malignant disease in the past 5 years except basal cell carcinoma
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])